Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Open Label Study of CM-AT for the Treatment of Children With Autism
Sponsor: Curemark
Summary
This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.
Official title: An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Key Details
Gender
All
Age Range
3 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
405
Start Date
2015-10
Completion Date
2028-01
Last Updated
2026-03-18
Healthy Volunteers
No
Conditions
Interventions
CM-AT
Single unit does powder of active substance (CM-AT) administered 3 times per day
Locations (31)
Southwest Autism Research & Resource Center (S.A.R.R.C.)
Phoenix, Arizona, United States
University of Arizona, Pediatrics Multidisciplinary Research Unit
Tucson, Arizona, United States
Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.)
Little Rock, Arkansas, United States
N.R.C. Research Institute
Orange, California, United States
M.I.N.D. Institute (Univ.of California, Davis)
Sacramento, California, United States
University of California (U.C.S.F.)
San Francisco, California, United States
IMMUNOe Research Centers
Centennial, Colorado, United States
Yale Child Study Center
New Haven, Connecticut, United States
Segal Institute For Clinical Research
North Miami, Florida, United States
Advent Health -Lake Mary Pediatrics
Orange City, Florida, United States
A.P.G. Research
Orlando, Florida, United States
Research Institute of Deaconess Clinic
Newburgh, Indiana, United States
Lake Charles Clinical Trials
Lake Charles, Louisiana, United States
L.S.U. Health Sciences Center
Shreveport, Louisiana, United States
Detroit Clinical Research Center, P.C.
Bingham Farms, Michigan, United States
Children'S Specialized Hospital
Egg Harbor, New Jersey, United States
Children's Specialized Hospital
Toms River, New Jersey, United States
Clinical Research Center of Nj
Voorhees Township, New Jersey, United States
Lovelace Scientific Resources
Albuquerque, New Mexico, United States
Richmond Behavioral Associates
Staten Island, New York, United States
Montefiore Med.Cneter, Autism & Obsessive Compulsive Spectrum Program
The Bronx, New York, United States
Duke Center For Autism and Brain Development
Durham, North Carolina, United States
Cleveland Clinic Autism Center
Cleveland, Ohio, United States
Omega Medical Research
Warwick, Rhode Island, United States
Carolina Clinical Trials, Inc.
Charleston, South Carolina, United States
Vanderbilt Universtiy Med.Center-Treatment&Research Inst. For Asd
Nashville, Tennessee, United States
University of Texas, Houston-Behavioral & Biomedical Sciences
Houston, Texas, United States
Focus Center of Clinical Research
Clinton, Utah, United States
University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences
Charlottesville, Virginia, United States
Neuroscience, Inc
Herndon, Virginia, United States
Carilion Clinic-Virginia Tech, Carilion School of Medicine
Roanoke, Virginia, United States